insitro ← all

Gwangju Dementia Cohort Cohort

Building the evidence to overcome dementia — with data.

GARD builds a large-scale multi-omics cohort — integrating clinical, genomic, brain-imaging and biospecimen data — to study the early diagnosis and prevention of dementia.

251TB+
Multi-omics data
23,000
Cohort participants
SCI
Int'l publications
Chosun UniversityMinistry of Science & ICTGwangjuKBRIBoston University
Cohort · community-based
Multi-omics · integrated
Prevention · pre-symptomatic

Research Pillars

Three pillars, one goal.

01

Cohort building & operation

We follow a large community-based cohort over time to observe changes before and after dementia onset.

02

Integrated multi-omics analysis

We integrate genomic, imaging, fluid-biomarker and clinical data to uncover the causes and progression of dementia.

03

Early diagnosis & prevention

We identify risk at the pre-symptomatic stage and build the evidence base for prevention and intervention.

Kun Ho Lee, Director

Director's message

"We build the evidence to overcome dementia."

Dementia is no longer a challenge for individuals or single families alone. GARD follows participants from before symptoms appear and integrates clinical, genomic, brain-imaging and biospecimen data to build the evidence for early diagnosis and prevention.

Kun Ho Lee · Director, Gwangju Alzheimer's & Related Dementia Cohort

News

Latest from the cohort.

2026ResearchGARD cohort findings published in an international journal
2026NoticeMulti-omics data platform status released
2025ResearchAI-based brain imaging analysis results announced

Research collaboration & inquiries

We welcome inquiries on joint research, data use, and visits.

Contact us